Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.37 +0.51 (+1.77%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Cost of Revenue (2021 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) recorded Cost of Revenue of $10.58 million in the quarter ended Jun 30, 2026, up 100.1% from $5.29 million a year earlier and up 88.3% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Cost of Revenue (2021 - 2026) Analysis & Trends

On a TTM basis, Lakefront Biotherapeutics' Cost of Revenue came in at $34.61 billion as of Jun 30, 2026; for the year ended Dec 31, 2025, it was $33.6 billion.

  • Annual Cost of Revenue has a four-year compound annual growth rate of 1049.0% (years ended Dec 2021 to Dec 2025).
  • Across earlier years, Cost of Revenue came in at $37.73 million in the year ended Dec 31, 2024 (+94.6%), $19.39 million in the year ended Dec 31, 2023 (+52.3%), $12.73 million in the year ended Dec 31, 2022 (+560.4%) and $1.93 million in the year ended Dec 31, 2021.
  • Quarterly Cost of Revenue has ranged from -$577,212 in the quarter ended Jun 30, 2024 to $34.58 billion in the quarter ended Dec 31, 2025 over the past five years.
  • On a year-over-year basis, Cost of Revenue rose in three of the last six quarters, with growth averaging 89.8%.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 421.7% in the quarter ended Mar 31, 2025, against a decline of 90.6% in the quarter ended Dec 31, 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $5.62 million (quarter ended Mar 31, 2026), $34.58 billion (quarter ended Dec 31, 2025) and $12.72 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Lakefront Biotherapeutics 1.94 Bn 1.94 Bn 3.51 Mn 10.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.58 Mn
Mar 31, 2026 5.62 Mn
Dec 31, 2025 34.58 Bn
Sep 30, 2025 12.72 Mn
Jun 30, 2025 5.29 Mn
Mar 31, 2025 14.44 Mn
Dec 31, 2024 1.82 Mn
Sep 30, 2024 18.79 Mn
Jun 30, 2024 -577,211.74
Mar 31, 2024 2.77 Mn
Dec 31, 2023 19.37 Mn
Sep 30, 2023 6.25 Mn
Jun 30, 2023 4.60 Mn
Mar 31, 2023 3.83 Mn
Dec 31, 2022 4.22 Mn
Sep 30, 2022 2.46 Mn
Jun 30, 2022 2.76 Mn
Mar 31, 2022 3.27 Mn
Dec 31, 2021 1.06 Mn
Sep 30, 2021 825,501.13
API Access

Lakefront Biotherapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=LKFT&period=max&api_key=YOUR_API_KEY